Nautilus Biotechnology Inc (NAUT) Stock Price, Quote & News

Company Profile

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes an end-to-end solution comprising instruments, consumables, and software analysis. It also offers a proteome analysis system, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libra...

Industry: Biotechnology

Sector: Healthcare

Phone: 206 333 2001

Website: www.nautilus.bio

Address:

2701 Eastlake Avenue East, Seattle, United States

EmproX Feb. 23 at 12:42 PM

$PHOE $NAUT $WTF $TALK •••

0 · Reply

bilocelhi Feb. 20 at 1:40 PM

$NAUT still only 2K watchers, flying very well under the radar. Gonna be 🔥 , shortly

0 · Reply

bilocelhi Feb. 20 at 3:21 AM

$CAPR take a look at $NAUT going to make eye-popping moves. Current gradual set-up is 🔥

1 · Reply

bilocelhi Feb. 20 at 12:51 AM

$NAUT 💯

0 · Reply

bilocelhi Feb. 19 at 10:45 PM

$NAUT 33% since nice, headed to $5 give or take a week

0 · Reply

bilocelhi Feb. 19 at 10:44 PM

$NAUT why not? About to be $5

0 · Reply

birdupyoubird Feb. 19 at 5:53 PM

$NAUT keep moving up 💪

0 · Reply

OfficialStocktwitsUser Feb. 19 at 4:46 PM

$NAUT RSI: 80.34, MACD: 0.1369 Vol: 0.23, MA20: 2.18, MA50: 2.06 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Omega_Proxy Feb. 19 at 12:50 AM

$NAUT Well shouldn't have added more today....

0 · Reply

PLATINUM_TRADES Feb. 18 at 4:46 PM

$NAUT $2.85 High still good enough for good profits today on out overnight swing... Will revisit later🚨 🚨

0 · Reply

Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

Nov 3, 2025, 8:00 AM EST - 4 months ago

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

Oct 28, 2025, 11:31 AM EDT - 4 months ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2025 Earnings Call Transcript

Sep 8, 2025, 4:57 PM EDT - 5 months ago

Nautilus Biotechnology, Inc. (NAUT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 27, 2025, 8:00 AM EDT - 6 months ago

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

Aug 1, 2025, 4:45 PM EDT - 7 months ago

Nautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Conference Call Transcript

Jul 31, 2025, 8:00 AM EDT - 7 months ago

Nautilus Biotechnology Reports Second Quarter 2025 Financial Results

Jul 15, 2025, 8:00 AM EDT - 7 months ago

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

Apr 29, 2025, 1:01 PM EDT - 10 months ago

Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript

Feb 28, 2025, 6:59 PM EST - 1 year ago

Nautilus: Trading Below An Albeit Lower Net Cash Figure

Feb 28, 2025, 7:25 AM EST - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 9:50 AM EST - 1 year ago

Nautilus Biotechnology layoffs 16% of workforce, plans release of commercial platform in 2026

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award

Oct 30, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

Oct 29, 2024, 1:17 PM EDT - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript

Jul 30, 2024, 3:16 PM EDT - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

Apr 30, 2024, 1:19 PM EDT - 1 year ago

Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Apr 11, 2024, 8:00 AM EDT - 2 years ago

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

Feb 28, 2024, 1:13 PM EST - 2 years ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:00 AM EST - 2 years ago

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 22, 2024, 8:00 AM EST - 2 years ago

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

Feb 7, 2024, 8:00 AM EST - 2 years ago

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Nov 30, 2023, 8:00 AM EST - 2 years ago

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Nov 1, 2023, 8:05 AM EDT - 2 years ago

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

Oct 31, 2023, 11:22 AM EDT - 2 years ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript

Oct 31, 2023, 8:05 AM EDT - 2 years ago

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

Oct 11, 2023, 8:05 AM EDT - 2 years ago

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

Aug 4, 2023, 8:00 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

Aug 2, 2023, 1:33 PM EDT - 2 years ago

Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 7:30 AM EDT - 2 years ago

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

Jul 11, 2023, 9:23 AM EDT - 2 years ago

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

May 24, 2023, 8:05 AM EDT - 2 years ago

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

May 2, 2023, 6:30 AM EDT - 3 years ago

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

Apr 18, 2023, 4:05 PM EDT - 3 years ago

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

Mar 23, 2023, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

Feb 25, 2023, 3:09 PM EST - 3 years ago

Nautilus Biotechnology, Inc. (NAUT) Q4 2022 Earnings Call Transcript

Feb 23, 2023, 6:05 AM EST - 3 years ago

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Feb 21, 2023, 8:00 AM EST - 3 years ago

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

Jan 26, 2023, 8:00 AM EST - 3 years ago

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

Jan 26, 2023, 7:45 AM EST - 3 years ago

Nautilus Biotechnology Expands to San Diego

Jan 19, 2023, 8:00 AM EST - 3 years ago

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

Dec 27, 2022, 10:53 AM EST - 3 years ago

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs

Nov 1, 2022, 2:35 PM EDT - 3 years ago

Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript

Nov 1, 2022, 6:05 AM EDT - 3 years ago

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

Sep 23, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

Sep 1, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

Aug 30, 2022, 8:00 AM EDT - 3 years ago

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

EmproX Feb. 23 at 12:42 PM

$PHOE $NAUT $WTF $TALK •••

0 · Reply

bilocelhi Feb. 20 at 1:40 PM

$NAUT still only 2K watchers, flying very well under the radar. Gonna be 🔥 , shortly

0 · Reply

bilocelhi Feb. 20 at 3:21 AM

$CAPR take a look at $NAUT going to make eye-popping moves. Current gradual set-up is 🔥

1 · Reply

bilocelhi Feb. 20 at 12:51 AM

$NAUT 💯

0 · Reply

bilocelhi Feb. 19 at 10:45 PM

$NAUT 33% since nice, headed to $5 give or take a week

0 · Reply

bilocelhi Feb. 19 at 10:44 PM

$NAUT why not? About to be $5

0 · Reply

birdupyoubird Feb. 19 at 5:53 PM

$NAUT keep moving up 💪

0 · Reply

OfficialStocktwitsUser Feb. 19 at 4:46 PM

0 · Reply

Omega_Proxy Feb. 19 at 12:50 AM

$NAUT Well shouldn't have added more today....

0 · Reply

PLATINUM_TRADES Feb. 18 at 4:46 PM

$NAUT $2.85 High still good enough for good profits today on out overnight swing... Will revisit later🚨 🚨

0 · Reply

PLATINUM_TRADES Feb. 18 at 12:26 PM

$NAUT Breakout in September was awesome.... Then kept the$2.00 area before blastoff again... This may go over $3.00 now to keep the pattern🚨 🚨

0 · Reply

WOLFSTREET Feb. 18 at 7:56 AM

@Omega_Proxy Not WHO but WHAT, it is an invaluable software platform providing precise, consistent, and reliable awareness and predictive guidance as shown on a wild bronco like $NAUT

1 · Reply

DriftPhantom Feb. 18 at 6:57 AM

$NAUT Nautilus Biotechnology develops proteomics tools, facing early-stage commercialization against established mass spectrometry players [citation:historical].

0 · Reply

StockScanners Feb. 18 at 6:32 AM

$NAUT keep watch if this holds above 2.50

0 · Reply

WOLFSTREET Feb. 17 at 9:28 PM

$NAUT 35% SMOOOOOOOTH But stand-by, CC says engines have not even warmed up.... Wooo Hooo

0 · Reply

bilocelhi Feb. 17 at 8:43 PM

$NAUT here we go

1 · Reply

topstockalerts Feb. 17 at 8:22 PM

$NAUT Where is it going next? Comment below

0 · Reply

topstockalerts Feb. 17 at 6:56 PM

$NAUT Setting up nicely for continuation. Price is consolidating near highs. That often leads to another push 🚀.

0 · Reply

EmproX Feb. 17 at 6:30 PM

$RAIN $NAUT $CPS $BDMD <€>^^

0 · Reply

EmproX Feb. 17 at 5:54 PM

$SIF $NAUT $KNRX $KNF ~~

0 · Reply

bilocelhi Feb. 12 at 6:07 PM

$NAUT due to explode soon

1 · Reply

NancyPeery1065 Feb. 11 at 3:02 PM

$NAUT Nautilus Biotechnology; proteomics tools; early-stage, unproven commercial traction; competes with established mass spec players.

0 · Reply

Market Cap	356.18M
Revenue (ttm)	0.00
Net Income (ttm)	-70.78M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	171,200
Avg Vol	220,208
Day's Range	N/A - N/A
Shares Out	126.31M
Stochastic %K	89%
Beta	1.49
Analysts	Strong Sell
Price Target	$2.50